|Day Low/High||9.90 / 10.49|
|52 Wk Low/High||9.83 / 20.48|
It is premature to declare the rotation back into small-cap stocks is dead.
I'm feeling better about more aggressive stock picking, but I'm staying selective.
Rebuying a stock that you have previously sold can be an extremely powerful trading strategy.
I'm hoping that we see some more rotational action rather than a broad market correction.
Trading in biotech stocks and a particular SPAC play are on my mind.
Quite a few stocks are fading right now -- not due to poor fundamentals, but due to lack of buying interest.
I'm currently heavily invested in several stocks that are drifting around as I'm quite confident that the eventual catalysts will come.
So far today, aggressive stock picking is looking like a possibility.
Trading in multiple time frames allows for more concentrated positions and bigger returns while staying diversified and reducing risk.
The essence of great trading isn't about predicting the future.
The key to effective trading isn't predicting future price -- it's dealing with current price action.
There is so much going on right now that it is overwhelming.
All these names, I believe, have potential positive catalysts, but they all can drift lower in a poor market.
It's premature to predict that a low has been made, but plenty of stocks are quite washed-out already and are starting to find support.
My primary goal is to stay flexible and not just sit there.
The best thing that can happen to this market technically are some pullbacks.
My bread and butter trade is to find stocks with solid fundamental stories and then aggressively trade the volatility around core positions.
The main themes are bitcoin, cannabis, stocks priced under $10, small biotechnology, and small-caps in general.
Study those charts and be ready to act as things develop.
This is how I am approaching the stock right now.
Small, aggressive traders are doing so well with the chasing that they are likely to continue for a while.
The folks that are waiting for the market collapse are going to have to keep waiting.
Last-minute tax planning, window dressing, and positioning are dominating the rather quiet action.
A few of these names continue to look good in 2021.
Aurinia Pharma has some positive catalysts, and I am taking partial gains in cannabis names as they remain strong.